Inhibitors Containing Pentabromodiphenyl Ether and Pharmaceutical Components Containing Pentabromodiphenyl Ether and Their Therapeutic Uses

摘要

Invention refers to formula compounds (I): in such compounds, R1, R2, R3, R4, L and A are defined in description and requirements, or salts acceptable for drugs that inhibit the activity of pentachloronitrobenzene (MTR). The invention also relates to pharmaceutical compounds including a prescription compound (I) or a prescription salt acceptable to drugs, as well as the use of a prescription compound (I) or a prescription salt acceptable to drugs in treatment.